We have developed a databank screening procedure, the In Silico Trans-splicing Retrieval System (ISTReS), to identify heterologous, spliced mRNAs with potential origin from chromosomal translocations, mRNA trans-splicing and multi-locus transcription. A parsing algorithm to screen cDNA versus genome Blast outputs was implemented. Key ®ltering criteria were Blast scores of b300, match lengths of b95% of the query sequences, junction of the two partners at exon±exon borders and concordant`sense/sense' reading orientation. ISTReS was validated by the successful identi®ca-tion of bona ®de chromosomal translocationderived fusion transcripts in the HGI and RefSeq databanks. The performance of ISTReS was veri®ed against recently identi®ed chimeric antisense transcripts, where it revealed essentially no independent proof of antisense transcription and absence of exon±exon borders at the chimeric join, consistent with an artefactual origin. Analysis of the UNIGENE database revealed 21 742 chimeric sequences overall that correspond to~1% of the database transcripts. Novel FOP-Rho GAP and methionyl tRNA synthetase-advillin chimeric mRNAs with the canonical features of heterologous-genes spliced-transcripts were identi®ed among 246 chimeras from the RefSeq databank. This suggests a frequency of canonically-spliced chimeras of~1% of all the hybrid sequences in current databanks. These ®nd-ings demonstrate the ef®ciency of ISTReS and the overall feasibility of sequence/structure-based strategies to search for chimeric mRNAs candidate to derive from the splicing of heterologous transcripts.
INTRODUCTION
Chromosomal translocations are frequently detected in hematologic and solid malignancies, where they can play a causative role or induce a cell growth selective advantage (1) . At the molecular level, they act through deregulation of gene expression or through the generation of fusion oncogenes. Examples of the former are translocations where a gene lands near enhancer elements, e.g. within immunoglobulin or T-cell receptor genes, or that disrupt the promoter region of c-myc (2) . However, chromosomal translocations in tumour cells much more frequently generate hybrid, oncogenic coding sequences (1) . Often, the corresponding hybrid proteins are signaling molecules and/or transcription factors that are deranged from their normal regulatory circuits or acquire novel functional properties. Disruption of regulatory pathways appears, thus, as a major and widespread consequence of the generation of chimeric mRNAs encoding hybrid oncogenic proteins.
Hybrids between heterologous mRNAs are also generated by mRNA trans-splicing. The latter was ®rst detected in vitro (3, 4) , but was subsequently shown to occur in vivo in several lower and higher eukaryotes (5) , including mammals (6±10). Major biological functions of the trans-splicing of a common spliced leader in trypanosomatids and nematodes are the processing of polycistronic transcription units and the regulation of the translation ef®ciency and stability of the resulting mRNAs (11) . On the other hand, the trans-splicing between heterologous transcripts in mammalian cells increases protein diversity through the joining of segments/domains originating from different genes (5) . Recent ®ndings indicate that each of the two mRNA moieties also carries speci®c regulatory signals that dictate the physical location of the mRNA and regulate its stability (12) .
Long transcription across neighbouring genes that normally act as independent transcription units, has been demonstrated in several cases (13±16). Similarly to the cases above, this results in hybrid, multi-locus transcripts, which often increase the diversity of the exon complement of the participating genes (13±16).
Chimeric transcripts in`antisense' orientation have also been recently identi®ed in the RefSeq and EMBL databanks (17) . The origin and role of these transcripts are not known (17) . However, natural, single-gene antisense mRNAs (18) are of frequent occurrence in mammals, including man (17, 19) , and may play a novel role in the regulation of gene expression. Thus, a similar regulatory role was suggested for the hybrid antisense mRNA.
Hence, diverse classes of hybrid mRNAs appear to play important functional roles in normal and transformed cells (1) . A whole-genome exploration for hybrid sequences is, thus, of interest, as it may identify novel members of these hybrid mRNA classes, and reveal common structure/sequence characteristics. However, the construction of cDNA libraries frequently presents with cDNA fusion artifacts, linked to incorrect ligation or abnormal reverse-transcription (20, 21) . Thus, rigorous retrieval and analysis strategies are required to distinguish between mRNA chimeras of potential physiological origin and artifacts. In this work, we have developed the In Silico Trans-splicing Retrieval System (ISTReS) to extract`spliced' chimeric mRNA from sequence databanks. Our ®ndings demonstrate the overall feasibility of this sequence/structure-based strategy and the ef®ciency of the ISTReS procedure.
MATERIALS AND METHODS

ISTReS strategy
Chimeric sequences from non-contiguous loci are generated through at least three different molecular mechanisms, i.e. chromosomal translocations (22) , mRNA trans-splicing (5) and transcription of long mRNA across neighbouring loci (13±16). In these cases the two heterologous mRNAs are typically joined together by splicing at conventional donoracceptor exon-bordering sites (see below). RNA±RNA recombination has also been demonstrated, and was shown not to follow the rules of conventional splicing (23±25). However, the in vivo frequency of this phenomenon is extremely low (24) and is largely limited to viral RNA sequences (25) . As a consequence, a general strategy was devised to identify hybrid mRNAs that are joined together following the sequence-structure rules of canonical mRNA splicing (26, 27) (Fig. 1) .
As shown in Figure 1A , whole cDNA sequence databanks (RefSeq, HGI, 31. jul. 2001 release, and subsets of theirs) were mapped onto the human genome by Blast analysis. Sequence databanks and analysis programs were downloaded to and utilised in two Digital Personal Workstations with Alpha 500 Mhz processors (780 and 255 Mb RAM, respectively) and a Digital AlphaStation 255 (128 Mb RAM).
Blast outputs were parsed for sequences that mapped to different loci (Fig. 1B) . A parsing algorithm written in Perl was implemented to this purpose. Filtering criteria validated during the screening were: a Blast score b300, a Blast match length of b95% of the query sequence, a minimal Blast match length of 200 nt [lower lengths were permitted in the analysis of the chimeric antisense sequence datasets (17) ], identity between the cDNA and genomic sequences of b97%. A gap of`10 nt between the two matches of the chimeric sequences was permitted. These criteria were devised to search with high-sensitivity and an acceptable stringency. For example, reasonable numbers of sequencing errors were tolerated, while good matches of short length were still highlighted.
As shown in Figure 1C , the identi®ed chimeras were excluded from further analysis if they: (i) comprised more than two segments, as they were likely to derive from the random co-ligation of unrelated cDNA fragments; (ii) could not be located on the human genome map, as this did not permit veri®cation of their origin from distinct loci; (iii) contained introns, as these were likely to derive from genomic DNA or, less frequently, from nuclear mRNA; (iv) had no independent evidence of`sense' transcription, i.e. no other independent mRNA or EST sequences corresponding to either of the fusion partners could be identi®ed; these sequences were likely to correspond to intergenic/non-transcribed regions of genomic DNA (see below for the antisense chimeras); (v) the fusion join corresponded to poly-linker sequences or enzyme sites utilized in the construction of the library; the chimeras contained vector (vi), mitochondrial (vii) or Escherichia coli (viii) sequences. Figure 1D shows that the selected mRNA chimeras were further analysed for junction of the two partners at exon±exon borders and for concordant`sense/sense' (or`antisense/ antisense') reading orientation. The reading orientation of the mRNA partners of the chimeric sequences was determined by comparison with independent transcripts in the nonredundant GenBank/EMBL sequence collection. EST sequences were not utilised for this purpose, because of their unreliable orientation, due to automated sequencing and non-curated deposit in databanks. In the case of non-characterised transcripts additional evidence was contributed by a structural analysis of the corresponding transcription units at the genomic level [promoter sequences (28) , transcription start sites (29) , mRNA cleavage/poly-A addition signals (30) and untranslated regions (31)].
Online sequence analysis sites
Sequences were matched against the non-redundant and human_EST datasets using Blastn (http://www.ncbi.nlm.nih. gov/BLAST/) (32) . Query sequences were mapped onto the human genome using Megablast (http://www.ncbi.nlm.nih. gov/genome/seq/HsBlast.html) (0.01 level expectation and default ®ltration). Sim4 (http://pbil.univ-lyon1.fr/sim4.html) (33) was used to de®ne the exon±intron borders of the chimera partners.
RESULTS AND DISCUSSION
mRNA chimeras from two different genes most commonly arise from chromosomal translocations (22) , mRNA transsplicing (5) or transcription across neighbouring loci (13±16). As hybrid mRNA sequences play important roles in cell transformation or in regulatory pathways in normal cells (1), a whole-genome exploration, through the analysis of sequence databanks, may offer novel means to reveal other members of these classes and shared structure/sequence characteristics. Most chromosomal translocations identi®ed in cancer cells occur in intronic regions (22, 34) , likely because of the longer overall length of introns and of the selective pressure for a functional protein, advantageous for cancer cell growth. The two partners in the chimera (as processed from nuclear mRNA precursors) are subsequently joined at exon±exon borders (22) . Trans-spliced transcripts originate from the joining of independently transcribed mRNAs (5). This post-translational processing follows the rules of, and is performed by, the canonical cis-splicing apparatus, resulting in the joining of heterologous mRNAs at canonical exon±exon borders (3±5). Long, multi-locus transcription has been observed in several instances (13±16). The processing of the resulting long, immature mRNAs results in the joining of coding regions at exon±exon sites (13±16). Thus, joining at exon-bordering sites is a common feature of all of the above classes of heterologous mRNA chimeras.
On the other hand, cDNA construction artifacts (end-to-end joining or recombination) and the rare products of RNA±RNA recombination in vivo (24) are unlikely to join by chance at exact exon±exon borders. Moreover, while the trans-splicing of heterologous, independently transcribed mRNAs is expected to join`sense/sense' sequences, cDNA/cDNA recombination or fusion would be expected to randomly generatè sense/antisense' sequences in one-half of the cases. Random cDNA artifacts would also be expected to arise in proportion to the abundance of the corresponding mRNA. Hence, frequent transcripts, e.g. for ribosomal proteins, elongation factors, cytoskeletal proteins, globins (in hematopoietic cells) (30) , are expected to be frequent among artefactually generated chimeric mRNA.
The concepts above were incorporated in the ISTReS screening strategy and algorithm (Fig. 1) . The goal of ISTReS is to identify mRNA chimeras, whether from chromosomal translocations, mRNA trans-splicing or multi-locus transcription, within human transcript datasets. The criteria detailed in Material and Methods were implemented in the proof-ofprinciple searches presented here. Blast scores of b300 were used as a cut-off in the analysis of whole sequence databanks. In combination with the sequence identity criteria this also allowed to select for good sequence matches of short length. THC480561  MLL-hCDCrel  THC482203  ETV6-NTRK3  THC558963  AML1-EVI1  THC558964  AML1-MTG8  THC519492  Rho GEF-PKA AP (LBC)  L21756, S76343  AML1-EAP  X56348  SURF-RET  X92120  EWS-CHOP  M73779, M82827 PML-RARa Y15911, Y15912, Y16345, Y16344, Y16343, Y16342, Y16341
COL1A1-PDGFB a Acronyms of the 5¢ and 3¢ partners of the fusion oncogenes identi®ed in the RefSeq and HGI databanks. Search parameters of the Blast search were: Blast score b300; identity between the cDNA and genomic sequence b97%; match length b200 bp and b95% of the query sequence; gap between the two sequences`10 bases. 
a AC: accession number of the chimeric sequences identi®ed during the search in the HGI databank that did not pass the ISTReS inclusion/exclusion criteria (Fig. 1) . The accession numbers of the partners in the chimera are in parentheses below the sequence names. This cut-off value was relaxed (b80) for the analysis of the chimeric antisense transcript dataset, as this contained even shorter sequence segments (17) . We veri®ed the capability of ISTReS to detect actual chimeric sequences in the curated databanks Human Gene Index (HGI, TIGR) (http://www.tigr.org/tdb/hgi/) and RefSeq (http://www.ncbi.nlm.nih.gov/LocusLink/refseq.html) (the latter search was kindly supported by the RefSeq curation staff). These searches were performed by Blast comparison of the HGI Tentative Human Consensus (THC) sequences and of the RefSeq candidates versus the human genome. Blast outputs were subsequently parsed for sequences that mapped to two different map locations.
Eighteen fusion sequences corresponding to ten experimentally veri®ed translocated oncogenes, i.e. MLL-hCDCrel, ETV6-NTRK3, AML1-EVI1, AML1-MTG8, Rho GEF-PKA AP (LBC), AML1-EAP, SURF-RET, EWS-CHOP, PMLRARa, COL1A1-PDGFB, were identi®ed (Table 1) , validating our search procedure. These searches also revealed a much larger number of chimeric sequences that did not meet the structural requirements expected from`physiological' fusion events. mRNA chimeras that failed the criteria outlined in Figure 1 are listed in Tables 2 and 3 . A comprehensive analysis of the Unigene database revealed 21 742 chimeric sequences, i.e.~1% of the total number of transcripts analysed (35) . Notably, several frequent mRNAs, e.g. for ribosomal 
a AC: accession number of the chimeric sequences identi®ed in the RefSeq databank that did not pass the ISTReS inclusion criteria (Fig. 1) . The accession numbers of the partners in the chimera are in parentheses below the sequence names. b BP: binding protein; EF: elongation factor; Rec.: receptor; RP: ribosomal protein; Sim.: similar to; I: IMAGE; EI: Euroimage; R: RIKEN. Abundant mRNA classes are in bold.
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proteins, were rather frequent among chimeric sequences, arguing in favour of a stocastic, artefactual nature. Of interest, intra-chromosomal hybrid sequences were 7.3% of all the RefSeq chimeras (Table 4 ) and 6.9% of the antisense chimeras (see below). As the fraction of the genome belonging to each separate chromosome ranges from 8.5% for chromosome 1 to 1.6% for the Y chromosome (mean: 4.8%) (36), our results appear close to what would be expected on stocastic grounds only, further supporting the random nature of most of the observed events. Rather interestingly, however, ISTReS screenings also identi®ed two novel chimeric mRNAs that demonstrated the canonical features of trans-spliced mRNAs (or long intergenic transcripts), FOP-Rho GAP and methionyl tRNA synthetaseadvillin. As these mRNAs were selected-out from 246 RefSeq chimeras (Fig. 2) , these ®ndings suggest a 1% frequency of 11q24  U38810  AF090693  10p13  XM_007172  13q12  AK027315  XM_027955  2q33  XM_058657  14q13  BC007768  NM_032891  3q29  BM045029  5q13  BC021561  AK024072  14q11  BC000502  18q21 a Accession number of the chimeric sequences identi®ed from the RefSeq databank that passed the inclusion criteria depicted in Figure 1C . The accession number of the corresponding fusion partners are also indicated. b Chromosomal map locations of the fusion partners of the chimeric sequences. Sequences from the same chromosome are in bold. (17, 19) . Previous experimental evidence had demonstrated the existence of natural antisense mRNA in eukaryotic cells (18) . However, their frequent occurrence in the human transcriptome was unexpected, raising the possibility that they may play a novel role in the regulation of gene expression (17, 19) . The identi®ed antisense chimeras were analysed with the ISTReS procedure. Thirty-one`antisense' chimeric sequences passed the screening criteria for trivial cDNA artefacts ( Fig. 1A±C ; Tables 5  and 6 ). Unexpectedly, though, independent evidence for antisense transcription proved almost nil (2 of 24 148 total hits), and in none of the latter cases were exon±exon borders detected at the chimeric join. Abundant mRNAs (for ribosomal proteins, globins, translation elongation factors, MHC invariant chain, b2-microglobulin etc.) were frequently present in the antisense chimeras, and hybrid sequences with ribosomal RNA (RNA polymerase I transcripts) (AF159295, AF095784) were also identi®ed. Moreover, transcription initiation and cleavage/poly-adenylation sites were frequently present at the fusion joins for both`sense' and`antisense' mRNA segments (17) ( Table 5 ). As`transcription initiation' and`cleavage/poly-adenylation' refer to the sense strand and do not have structural correlates for the`antisense' strand, this and the analyses above strongly suggested an artifactual origin of the antisense hybrid sequences.
In summary, we have developed the ISTReS algorithm and screening procedure to identify spliced, heterologous mRNAs in sequence databanks. Our ®ndings demonstrate the ef®-ciency of ISTReS. They also support the overall feasibility of sequence/structure-based strategies to select for chimeric mRNAs candidate to derive from the splicing of heterologous transcripts. Table 4 ). The 5¢ partner is FOP (translocated to the FGFR1 oncogene partner), whereas the 3¢ partner is T-cell activation Rho GTPase activating protein (GAP). The junction between the two partners is at exon±exon borders (exon II for FOP and exon IX for Rho GAP). The large distance between the two loci (6q27 versus 6q25) suggests a trans-splicing origin. However, as transcription is directed toward the centromere in both transcription units, this is formally consistent also with long, intergenic transcription. (Top) DNA sequence of the ®rst 780 bases of the chimeric mRNA; (bottom) sequence of the encoded chimeric protein. DNA bases and aminoacids surrounding the splice site are boxed. (B) Structure, sequence and translation product of the methionyl tRNA synthetase-advillin chimeric mRNA (Accession number: BC004134) ( Table 4 ). The 5¢ partner is the methionyl tRNA synthetase, whereas the 3¢ partner is advillin. The junction between the two partners is at exon±exon borders, (exon X for methionyl tRNA synthetase and exon II for advillin). The chromosomal position of methionyl tRNA synthetase is at 12q13.2, whereas that of advillin is at 12q13.1, and might be compatible with intergenic transcription. 
